Enrico Bastianelli, CEO, Bone Therapeutics- A game changer in orthopaedics?




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Enrico Bastianelli, CEO, Bone Therapeutics- A game changer in orthopaedics?
Released on: July 31, 2015. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Bone Therapeutics is a biotechnology company with a unique approach to the development of cell therapy products for bone fracture repair and fracture prevention.
  • Summary
  • Transcript
  • Participants
Bone Therapeutics is a biotechnology company with a unique approach to the development of cell therapy products for bone fracture repair and fracture prevention. Enrico Bastianelli, CEO of Bone Therapeutics tells Adrian Dawkes, VP at PharmaVentures how they are creating a new and unique treatment approach using differentiated bone-forming cells administered via a minimally invasive percutaneous procedure, that is expected to offer significant benefits over the current standard-of-care that often involves heavy surgery and long recovery periods.
Bone Therapeutics is a biotechnology company with a unique approach to the development of cell therapy products for bone fracture repair and fracture prevention. Enrico Bastianelli, CEO of Bone Therapeutics tells Adrian Dawkes, VP at PharmaVentures how they are creating a new and unique treatment approach using differentiated bone-forming cells administered via a minimally invasive percutaneous procedure, that is expected to offer significant benefits over the current standard-of-care that often involves heavy surgery and long recovery periods.
Bone Therapeutics